Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

U.S. patent issues for ImClone Systems' flk-1/KDR receptor-targeting antibodies

May 18, 1998

SU-5416 advances to phase I/II trials in Kaposi's sarcoma

May 18, 1998

Rhone-Poulenc Rorer expands licensing agreement with Enzon for Oncaspar

May 18, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Sparta completes patient treatment phase in Spartaject busulfan trial

May 15, 1998

Bis-imide antitumor agents developed at ADIR

May 14, 1998

Introgen receives patent protection for p53 gene therapy-chemotherapeutic drug combinations

May 13, 1998

Lilly develops assay for antitumor agent of natural origin

May 13, 1998

Novartis seek patients for phase III trials of PSC-833

May 13, 1998

XR-9576 enters clinical testing

May 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...